TOTAL VIEWS: 266
Objective: Medicine gene detection is used to guide the clinical use of clopidogrel and aspirin, in order to improve the efficacy and safety of clinical treatment. Methods: A total of 214 patients who received clopidogrel and aspirin treatment at the Affiliated Nanhua Hospital of the University of South China from March 2022 to February 2023 were selected. The medicine genes were detected by pyrosequencing. The genotype distribution of each gene locus was tested by the Hardy-Weinberg equilibrium test with SPSS 26.0. The patients' clinical information was analyzed using the chi-square test and binary logistic regression. Results: Among the 130 patients using clopidogrel, gene loci CYP2C19*2 681 G>A and CYP2C19*3 636 G>A were detected. Among the 84 patients using aspirin, gene loci PEAR1 G>A and LTC4S A>C were detected. The gene frequency distribution of the gene loci all accorded with Hardy-Weinberg equilibrium law, which indicated the sample was group representation. 59.2% of patients had clopidogrel resistance, 72.6% of patients had aspirin resistance, and 33.3% of patients had a high risk of urticaria when using aspirin. However, there was no significant difference in clopidogrel and aspirin resistance or urticaria risk in relation to patients' clinical information (P > 0.05). The results of medicine gene detection could be used as an independent indicator to predict the efficacy and safety of using clopidogrel and aspirin, providing important guidance for the clinical use of medication. Conclusion: Medicine gene detection could promote individualized medication and improve the efficacy and safety of clinical treatment when guiding the use of clopidogrel and aspirin.
[1] Goldfarb MJ, Bechtel C, Capers Q 4th, et al. Engaging Families in Adult Cardiovascular Care: A Scientific Statement from the American Heart Association. Journal of the American Heart Association. 2022;11(10):e025859.
[2] Pereira NL, Rihal C, Lennon R, et al. Effect of CYP2C19 genotype on ischemic outcomes during oralp2y 12 inhibitor therapy. JACC-Cardiovascular Interventions. 2021;14(7):739-750.
[3] Lee YC, Liao YC, LIN C J, et al. Baseline P2Y12 reactivity, kidney function, and CYP2C19 genotype determine clopidogrel responsiveness in acute stroke. Scientific Reports. 2023;13(1):8085.
[4] Kazui M, Nishiya Y, Ishizuka T, et al. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metabolism & Disposition the Biological Fate of Chemicals. 2010;38(1):92-99.
[5] Patel S, Arya V, Saraf A, et al. Aspirin and Clopidogrel Resistance in Indian Patients with Ischemic Stroke and its Associations with Gene Polymorphisms: A Pilot Study. Annals of Indian Academy of Neurology. 2019;22(2).
[6] Paré G, Mehta SR, Yusuf S, et al. Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. New England Journal of Medicine. 2010;363(18):1704-1714.
[7] Lima JJ, Thomas CD, Barbarino J, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2C19 and proton pump inhibitor dosing. Clinical Pharmacology & Therapeutics. 2021;109(6):1417-1423.
[8] Scott SA, Sangkuhl K, Stein CM, et al. Clinical pharmacogenetics implementation consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clinical Pharmacology & Therapeutics. 2013;94(3):317-323.
[9] Hokimoto S, Akasaka T, Tabata N, et al. Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy. Thrombosis Research. 2015;135(6):1081-1086.
[10] The health and family planning commission of the People's Republic of China. Summary of the technical guidelines for column measurement of drug metabolism enzymes and drug action target genes (trial). Practical Organ Transplantation Electronic Journal. 2015;3(5):257-267.
[11] Huang H, Zhang S, Du H, Guo Y, Zheng H. Effect of Clopidogrel combined with aspirin in the treatment of acute progressive cerebral infarction: A retrospective single-center analysis. Pakistan Journal of Medical Sciences. 2024;40(5):891-895.
[12] Yao Y, Tang XF, Zhang JH, et al. Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention. Thrombosis Research. 2016;141:28-34.
[13] Hui Z, Lin S, Hui XL, et al. Gene polymorphism of aspirin-induced urticaria in children with Kawasaki disease. Frontiers in Pediatrics. 2019;7:505-505.
[14] Mastalerz L, Setkowicz M, Sanak M, et al. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. Journal of Allergy and Clinical Immunology. 2004;113(4):771-775.
[15] Mastalerz L, Setkowicz M, Sanak M, et al. Familial aggregation of aspirin-induced urticaria and leukotriene C synthase allelic variant. British Journal of Dermatology. 2006;154(2):256-260.
Clinical Medication Analysis of Clopidogrel and Aspirin Guided by Medicine Gene Detection
How to cite this paper: Dingding Kang, Liushan Wei, Lianmei Xu, Liwei Yi. (2024) Clinical Medication Analysis of Clopidogrel and Aspirin Guided by Medicine Gene Detection. International Journal of Clinical and Experimental Medicine Research, 8(4), 587-592.
DOI: https://dx.doi.org/10.26855/ijcemr.2024.10.009